Skip to main content

Peer Review reports

From: Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study

Original Submission
15 Sep 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Feb 2023 Reviewed Reviewer Report
16 Mar 2023 Reviewed Reviewer Report
5 May 2023 Reviewed Reviewer Report
6 Jun 2023 Author responded Author comments - Do-Youn Oh
Resubmission - Version 3
6 Jun 2023 Submitted Manuscript version 3
21 Jun 2023 Author responded Author comments - Do-Youn Oh
Resubmission - Version 4
21 Jun 2023 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
19 Sep 2023 Author responded Author comments - Do-Youn Oh
Resubmission - Version 8
19 Sep 2023 Submitted Manuscript version 8
17 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
18 Oct 2023 Editorially accepted
3 Nov 2023 Article published 10.1186/s12885-023-11539-1

You can find further information about peer review here.

Back to article page